Sign in
4

Changes in Ownership

CVRx, Inc. Filed Acc 0001415889-23-014406

VP OF GLOBAL CLINICAL RESEARCH acquired 778 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Galle Liz · VP OF GLOBAL CLINICAL RESEARCH

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-16 Exercise or conversion : show line 1 in the form +778 $0.24 $184 778 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-16 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −778 0 D
Loading xslF345X05/form4-10182023_081024.xml…